bluebird bio to Present at Goldman Sachs Global Healthcare Conference
June 07 2021 - 4:05PM
Business Wire
bluebird bio, Inc. (NASDAQ: BLUE) today announced that members
of the management team will participate in the Goldman Sachs 42nd
Annual Global Healthcare Conference, Tuesday, June 8, at 8:50 a.m.
ET.
To access the live webcast of bluebird bio’s presentation,
please visit the “Events & Presentations” page within the
Investors & Media section of the bluebird bio website at
http://investor.bluebirdbio.com. A replay of the webcast will be
available on the bluebird bio website for 90 days following the
event.
About bluebird bio, Inc.
bluebird bio is pioneering gene therapy with purpose. From our
Cambridge, Mass., headquarters, we’re developing gene and cell
therapies for severe genetic diseases and cancer, with the goal
that people facing potentially fatal conditions with limited
treatment options can live their lives fully. Beyond our labs,
we’re working to positively disrupt the healthcare system to create
access, transparency and education so that gene therapy can become
available to all those who can benefit.
bluebird bio is a human company powered by human stories. We’re
putting our care and expertise to work across a spectrum of
disorders: cerebral adrenoleukodystrophy, sickle cell disease,
β-thalassemia and multiple myeloma, using gene and cell therapy
technologies including gene addition, and (megaTAL-enabled) gene
editing.
bluebird bio has additional nests in Seattle, Wash.; Durham,
N.C.; and Zug, Switzerland. For more information, visit
bluebirdbio.com.
Follow bluebird bio on social media: @bluebirdbio, LinkedIn,
Instagram and YouTube. bluebird bio is a trademark of bluebird bio,
Inc.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210607005708/en/
Investors & Media
Investors:
Elizabeth Pingpank, 617-914-8736 epingpank@bluebirdbio.com
Media:
Jenn Snyder, 617-448-0281 jsnyder@bluebirdbio.com
bluebird bio (NASDAQ:BLUE)
Historical Stock Chart
From Aug 2024 to Sep 2024
bluebird bio (NASDAQ:BLUE)
Historical Stock Chart
From Sep 2023 to Sep 2024